Study guide
27.1 The Acute Red Eye & Sudden Painless Visual Loss
MRCP UK
Track your progress as you read
Finished sections get a check mark.
1 MRCP(UK) Part 1: Exam Overview, Blueprint & Strategy
1.1 Part 1 Format, Delivery and Fees 1.2 The Official Blueprint and Mark Allocation 1.3 Scaled Scoring, Attempt Limits and Best-of-Five Technique
2 Clinical Sciences: Cellular, Genetic & Molecular Medicine
2.1 Organelles, Cytoskeleton & Membrane Transport 2.2 Cell Cycle Control, Apoptosis & Cell Signalling 2.3 Mendelian & Non-Mendelian Inheritance 2.4 Trinucleotide Repeat Disorders & Chromosomal Abnormalities 2.5 Purine, Pyrimidine Metabolism & the Porphyrias 2.6 Glycogen, Lipid Storage & Amino Acid Disorders
3 Clinical Sciences: Anatomy, Physiology & Immunology
3.1 Clinical & Cross-Sectional Anatomy 3.2 Systemic Clinical Physiology & Homeostasis 3.3 Clinical Immunology & Hypersensitivity Reactions
4 Clinical Sciences: Statistics, Epidemiology & Trial Design
4.1 Study Designs & Evidence Hierarchy 4.2 Diagnostic Testing, Screening & Predictive Values 4.3 Statistical Analysis & Risk Quantification
5 Clinical Pharmacology, Therapeutics & Toxicology
5.1 Pharmacokinetics & Pharmacodynamics 5.2 Cytochrome P450 Systems & High-Risk Drug Interactions 5.3 Adverse Drug Reactions & Therapeutic Drug Monitoring 5.4 Paracetamol & Salicylate Poisoning 5.5 Toxidromes, Antidotes, Carbon Monoxide & Toxic Alcohols
6 Cardiology: Coronary Artery Disease & Heart Failure
6.1 Acute Coronary Syndromes & Myocardial Infarction 6.2 Heart Failure & Cardiomyopathies 6.3 Cardiac Assessment & ECG Interpretation
7 Cardiology: Arrhythmias, Valvular & Pericardial Disease
7.1 Atrial Fibrillation, Narrow & Broad Complex Tachycardias 7.2 Bradyarrhythmias, Conduction Block & Antiarrhythmic Drugs 7.3 Valvular Heart Disease & Murmur Interpretation 7.4 Infective Endocarditis 7.5 Pericardial & Acute Aortic Diseases
8 Respiratory Medicine: Airway & Parenchymal Lung Disease
8.1 Asthma: Diagnosis, Chronic Management & Acute Attacks 8.2 COPD: GOLD Staging, Stable Management, Exacerbations & NIV 8.3 Interstitial Lung Disease & Sarcoidosis 8.4 Respiratory Infections & Bronchiectasis
9 Respiratory Medicine: Vascular, Pleural & Sleep Disorders
9.1 Venous Thromboembolism & Pulmonary Embolism 9.2 Pleural Effusion & Pneumothorax 9.3 Respiratory Failure & Sleep-Disordered Breathing
10 Gastroenterology: Luminal Gastrointestinal Disease
10.1 GORD, Barrett's Oesophagus & Oesophageal Motility Disorders 10.2 Peptic Ulcer Disease, Helicobacter pylori & Zollinger-Ellison Syndrome 10.3 Crohn's Disease, Ulcerative Colitis & Extraintestinal Manifestations 10.4 IBD Medical Therapy, Coeliac Disease & Malabsorption 10.5 Acute Upper Gastrointestinal Bleeding: Risk Scores, Ulcer & Variceal Haemorrhage 10.6 Lower Gastrointestinal Disorders & Colonic Neoplasia
11 Gastroenterology: Liver, Biliary & Pancreatic Disease
11.1 Viral Hepatitis A to E 11.2 Autoimmune Hepatitis & Metabolic Liver Disease 11.3 Cirrhosis & Complications of Portal Hypertension 11.4 Cholestatic Liver Disease: PBC and PSC 11.5 Gallstone Disease, Biliary Sepsis & Pancreatitis
12 Endocrinology & Diabetes: Diabetes & Thyroid
12.1 Diabetes: Diagnostic Thresholds, Classification & Pathophysiology 12.2 NICE-Directed Type 2 Therapy & Microvascular Complications 12.3 Acute Diabetic Emergencies (DKA & HHS) 12.4 Thyrotoxicosis, Thyroiditis & Management of Hyperthyroidism 12.5 Hypothyroidism, Subclinical Disease & Thyroid Nodules
13 Endocrinology & Diabetes: Adrenal, Pituitary & Calcium
13.1 Hypopituitarism, Pituitary Apoplexy & Hyperprolactinaemia 13.2 Acromegaly, Diabetes Insipidus & SIADH 13.3 Cushing's Syndrome: Aetiology, Screening & Localisation 13.4 Adrenal Insufficiency & Endocrine Hypertension 13.5 Calcium Regulation & Hypercalcaemia 13.6 Hypocalcaemia & Metabolic Bone Disease
14 Renal Medicine: AKI, Glomerular & Tubulointerstitial Disease
14.1 Acute Kidney Injury & Chronic Kidney Disease 14.2 Nephrotic and Nephritic Syndromes & Primary Glomerular Disease 14.3 Rapidly Progressive Glomerulonephritis 14.4 Tubulointerstitial & Inherited Renal Diseases
15 Renal Medicine: Fluid, Electrolytes & Acid-Base Balance
15.1 Sodium & Water Disorders 15.2 Potassium, Magnesium & Phosphate Disorders 15.3 Acid-Base Disorders & Blood Gas Analysis
16 Neurology: Cerebrovascular, Headache & Demyelinating Disease
16.1 Stroke Classification, Brainstem Syndromes & Hyperacute Reperfusion 16.2 Secondary Prevention, TIA, Carotid Surgery & Intracranial Haemorrhage 16.3 Headache Disorders & Cranial Neuralgias 16.4 Multiple Sclerosis & Central Demyelinating Diseases
17 Neurology: Epilepsy, Movement Disorders & Neuromuscular Disease
17.1 Epilepsy & Acute Seizures 17.2 Movement Disorders & Cognitive Impairment 17.3 Neuromuscular Junction & Peripheral Nerve Disorders
18 Rheumatology: Inflammatory Arthritis & Connective Tissue Disease
18.1 Rheumatoid Arthritis: Pathophysiology, Clinical Features & Diagnosis 18.2 DMARDs, Biologics & Their Toxicities 18.3 Seronegative Spondyloarthropathies 18.4 Systemic Lupus Erythematosus & Drug-Induced Lupus 18.5 Systemic Sclerosis & Scleroderma Renal Crisis 18.6 Sjogren's Syndrome & Inflammatory Myopathies
19 Rheumatology: Systemic Vasculitis & Crystal Arthropathy
19.1 Vasculitis Classification, Large and Medium Vessel Disease 19.2 ANCA-Associated and Immune Complex Small Vessel Vasculitis 19.3 Gout & Calcium Pyrophosphate Deposition Disease
20 Infectious Diseases & Tropical Medicine
20.1 Sepsis-3 Definitions & the Sepsis Six 20.2 Bacterial Meningitis, CSF Interpretation & Toxic Shock Syndrome 20.3 Tuberculosis: Pathogenesis & Clinical Manifestations 20.4 Tuberculosis: Diagnosis & Anti-Tuberculous Therapy 20.5 HIV Infection & Opportunistic Diseases 20.6 Malaria: Species, Life Cycle & Severe Disease 20.7 Enteric Fever, Arboviral Infection & Tissue Parasites
21 Haematology: Anaemias & Red Cell Disorders
21.1 MCV-Based Diagnostic Approach to Anaemia 21.2 Haemolytic and Autoimmune Haemolytic Anaemias 21.3 Membranopathies, Enzymopathies, PNH & Sickle Cell Disease
22 Haematology: Malignancy, Coagulation & Transfusion Medicine
22.1 Acute Leukaemias 22.2 Chronic Leukaemias & Myeloproliferative Neoplasms 22.3 Lymphomas & Plasma Cell Dyscrasias 22.4 Coagulation Cascade & Inherited Bleeding Disorders 22.5 Thrombocytopenia & Thrombotic Microangiopathies 22.6 Transfusion Products & Acute Transfusion Reactions
23 Psychiatry in General Medicine
23.1 Mood & Psychotic Disorders in Medical Patients 23.2 Psychiatric Emergencies & Substance Misuse 23.3 Mental Capacity & UK Mental Health Law
24 Geriatric Medicine
24.1 Comprehensive Geriatric Assessment, Frailty, Delirium & Falls 24.2 Polypharmacy, Deprescribing & Pressure Ulcers
25 Dermatology
25.1 Inflammatory Skin Disease, Immunobullous Disorders & Severe Drug Eruptions 25.2 Cutaneous Malignancy
26 Oncology & Palliative Medicine
26.1 Neutropenic Sepsis, Spinal Cord Compression & SVC Obstruction 26.2 Hypercalcaemia of Malignancy & Tumour Lysis Syndrome 26.3 Palliative Care & End-of-Life Symptom Control
27 Medical Ophthalmology
27.1 The Acute Red Eye & Sudden Painless Visual Loss 27.2 Retinopathy in Systemic Disease
27.1 The Acute Red Eye & Sudden Painless Visual Loss
Key Takeaways Explain This Topic AI
Acute angle-closure glaucoma causes a fixed mid-dilated oval pupil, hazy cornea, severe pain, vomiting and haloes, and is precipitated by anticholinergics and dilating drops.
Central retinal artery occlusion gives a pale retina with a cherry-red spot and a relative afferent pupillary defect; central retinal vein occlusion gives widespread flame haemorrhages described as a stormy sunset.
Anterior uveitis causes a small, irregular pupil with ciliary flush and hypopyon, and is associated with HLA-B27 spondyloarthropathy, sarcoidosis and inflammatory bowel disease.
Last updated: September 2026
Medical ophthalmology encompasses ocular emergencies and the ocular manifestations of multisystem medical diseases. The MRCP(UK) Part 1 examination rigorously tests the differential diagnosis of the acute red eye, the clinical approach to sudden visual loss, retinal manifestations of vascular disease, and ophthalmic complications of systemic autoimmune disorders.
1. Differential Diagnosis of the Acute Painful Red Eye
Evaluating the acute painful red eye requires distinguishing between benign external ocular disease and vision-threatening intraocular conditions.
Condition Pain & Vision Pupillary Finding Cornea & Anterior Chamber Conjunctival Injection Systemic / Etiological Associations
Acute Angle-Closure Glaucoma (AACG) Severe, boring pain radiating to brow/head; blurred vision, haloes around lights ; nausea, vomiting Mid-dilated, fixed, oval , non-reactive "Steamy" / hazy (epithelial oedema); shallow chamber; IOP > 40–50 mmHg Severe ciliary flush / diffuse conjunctival injection Hyperopia (short axial length), shallow anterior chamber, mydriatic drugs, dim light
Acute Anterior Uveitis (Iritis) Deep, aching ocular pain; intense photophobia ; mildly blurred vision Small, constricted, or irregular (posterior synechiae) Clear cornea; keratic precipitates (endothelial deposits); cells & flare in anterior chamber; hypopyon Ciliary flush (circumcorneal violaceous ring) HLA-B27 (ankylosing spondylitis, reactive arthritis, IBD, psoriatic arthritis), sarcoidosis, Behçet's
Scleritis Severe, deep, boring nocturnal pain radiating to temple/jaw, waking patient; visual acuity preserved or mild drop Normal, reactive Clear cornea; scleral oedema; deep violaceous hue ; tender to gentle touch Deep episcleral vessels do NOT blanch with phenylephrine 2.5% Systemic autoimmune disease (>50%) : Rheumatoid arthritis, GPA (Wegener's), relapsing polychondritis, SLE
Episcleritis Mild discomfort, grittiness, or irritation; no severe pain ; normal vision Normal, reactive Completely clear cornea; normal anterior chamber Sectoral or diffuse superficial bright redness; vessels blanch with phenylephrine 2.5% Usually idiopathic; young adults; benign, self-limiting
Microbial Keratitis (Corneal Ulcer) Severe ocular pain, foreign body sensation, marked photophobia, blurred vision, discharge Normal or sluggish Focal white/opaque corneal infiltrate ; epithelial defect staining with fluorescein Intense ciliary and conjunctival injection Contact lens wear ( Pseudomonas aeruginosa , Acanthamoeba ), corneal trauma, HSV dendritic ulcer
Acute Angle-Closure Glaucoma (AACG)
Pathophysiology: Occurs in anatomically predisposed eyes with a shallow anterior chamber (hyperopes, elderly with thickening cataracts). In mid-dilation, the peripheral iris apposes the anterior lens surface (pupillary block), causing pressure in the posterior chamber to rise, which bows the peripheral iris forward ( iris bombé ) against the trabecular meshwork, completely obstructing aqueous outflow.
Signs: Extremely firm, stony-hard globe on digital palpation through closed eyelids; intraocular pressure (IOP) markedly elevated (40–70 mmHg; normal 10–21 mmHg); "steamy" cornea with microcystic epithelial oedema; fixed, mid-dilated, vertically oval pupil.
Emergency Management Protocol:
Intravenous Acetazolamide 500 mg stat: Carbonic anhydrase inhibitor that rapidly reduces aqueous humour production by the ciliary body epithelium.
Topical Beta-Blocker: Timolol 0.5% drops (decreases aqueous production).
Topical Alpha-2 Agonist: Apraclonidine 1% drops (reduces aqueous production and enhances uveoscleral outflow).
Topical Pilocarpine 2%: Muscarinic agonist that stimulates the pupillary sphincter, inducing miosis to pull the peripheral iris root away from the trabecular meshwork (ineffective when IOP > 40–50 mmHg due to pressure-induced iris ischaemia; instil once IOP begins to fall).
Hyperosmotic Agent: Intravenous mannitol 20% (1–2 g/kg over 45 minutes) if IOP remains refractory.
Definitive Treatment: Bilateral Nd:YAG laser peripheral iridotomy (LPI) . Creates a full-thickness bypass hole in the peripheral iris, equalizing anterior and posterior chamber pressures. Prophylactic iridotomy of the unaffected contralateral eye is mandatory because anatomical predisposition is bilateral.
Anterior Uveitis (Iritis)
Clinical Manifestations: Circumcorneal injection ( ciliary flush ), severe aching pain, pronounced photophobia (direct and consensual pupillary constriction elicits excruciating pain due to spasm of the inflamed ciliary muscle and iris sphincter). Slit-lamp biomicroscopy reveals inflammatory leukocytes ( cells ) and protein exudate ( flare ) circulating in the anterior chamber, keratic precipitates on the corneal endothelium, and occasionally a gravitational layer of leukocytes ( hypopyon ).
Posterior Synechiae: Adhesions between the inflamed pupillary margin of the iris and the anterior lens capsule produce an irregular, scalloped, fixed pupil and can precipitate secondary angle-closure glaucoma.
Treatment: Topical corticosteroids ( dexamethasone 0.1% or prednisolone acetate 1% drops ) to suppress uveal inflammation, combined with a topical cycloplegic/mydriatic agent ( cyclopentolate 1% or atropine 1% ). Cycloplegics paralyze the ciliary muscle to relieve excruciating photophobic ciliary spasm and maintain pupillary dilation, breaking and preventing posterior synechiae.
Scleritis vs. Episcleritis: The Phenylephrine Blanching Test
Scleritis involves destructive inflammation of the deep episcleral and scleral vascular plexuses. Instillation of topical phenylephrine 2.5% drops constricts the superficial conjunctival and episcleral vessels (causing prompt blanching in benign episcleritis), but fails to blanch the deep scleral vessels in scleritis .
Scleritis can cause scleral necrosis and globe perforation ( scleromalacia perforans , classical in rheumatoid arthritis). Topical steroids are ineffective for anterior scleritis; it mandates oral NSAIDs or high-dose systemic corticosteroids / biologic immunosuppression .
Microbial Keratitis & Herpes Simplex Keratitis
Microbial Keratitis: Contact lens wearers are prone to aggressive Gram-negative infection by Pseudomonas aeruginosa , which secretes elastases and proteases causing rapid corneal liquefaction ("melting") and perforation within 24–48 hours; treated with intensive hourly fluoroquinolone monotherapy (e.g. ofloxacin 0.3%) or fortified cephalosporin/aminoglycoside drops.
Herpes Simplex Virus (HSV) Keratitis: Presents with foreign body sensation, redness, and photophobia. Staining with 1% fluorescein under cobalt-blue illumination reveals a pathognomonic dendritic ulcer (branching epithelial lesion with terminal bulbs) associated with decreased corneal sensation (tested with a fine wisp of cotton wool). Treated with topical aciclovir 3% eye ointment 5 times daily. CRITICAL EXAM WARNING: Topical corticosteroids are absolutely contraindicated in dendritic ulcers , as steroids suppress local viral immunity, transforming a linear ulcer into an extensive, destructive "geographic" or "amoeboid" ulcer with imminent corneal perforation.
- 2. Sudden Painless Loss of Vision Sudden Painless Loss of Vision Algorithms
- |
- +-------------------+---------------+-------------------+-------------------+
- | | | |
- CRAO (Artery) CRVO (Vein) AION (Optic Nerve) Retinal Detachment
- Embolic stroke - Thrombosis / Hyperviscosity - Arteritic (GCA) - Rhegmatogenous
- RAPD present - RAPD absent/mild vs Non-arteritic - Photopsia / Floaters
- Cherry-red spot - 'Blood & thunder' fundus - Altitudinal field - 'Dark curtain' defect
- Pale milky retina - Risk of 100-day glaucoma defect - Elevated grey retina
- Exclude GCA - Anti-VEGF / PRP - High ESR/CRP (GCA) with folds
- Central Retinal Artery Occlusion (CRAO)
Pathophysiology: Ophthalmic equivalent of an acute ischemic cerebral stroke; thromboembolism lodged in the central retinal artery (arising from internal carotid atheroma or cardiac sources: atrial fibrillation, valvular vegetations).
Presentation: Catastrophic, sudden, painless, profound monocular visual loss (acuity dropped to counting fingers or hand movements).
Physical Signs: Marked Relative Afferent Pupillary Defect (RAPD / Marcus Gunn pupil) .
Fundoscopy:
Diffusely pale, opaque, milky-white edematous retina (intracellular cloudy swelling of ischemic retinal ganglion cells).
Pathognomonic "Cherry-Red Spot" at the Fovea: The fovea centralis is extremely thin and devoid of overlying ganglion cell layers; it is nourished directly by the underlying choroidal circulation, allowing the vivid reddish choroid to shine through the surrounding opaque retina.
Severe retinal arteriolar attenuation with segmenting of the blood column ( "box-carring" / cattle-trucking ).
Emergency Management: Retinal tissue suffers irreversible infarction within 90 to 100 minutes . Immediate maneuvers (ocular massage, anterior chamber paracentesis, sublingual isosorbide dinitrate) aim to dislodge the embolus into peripheral arterioles. Urgent systemic workup: Carotid Doppler ultrasonography, echocardiogram, Holter ECG, and immediate ESR/CRP to exclude Giant Cell Arteritis (GCA) .
Central Retinal Vein Occlusion (CRVO)
Pathophysiology: Thrombosis of the central retinal vein at or posterior to the lamina cribrosa.
Risk Factors: Advancing age, systemic hypertension, diabetes mellitus, primary open-angle glaucoma, and hyperviscosity syndromes (polycythaemia vera, multiple myeloma, Waldenström's macroglobulinaemia, antiphospholipid syndrome).
Presentation: Sudden or subacute, painless visual blurring or moderate-to-severe visual impairment.
Fundoscopy: Classic "stormy sunset" or "blood and thunder" appearance :
- Widespread, dramatic flame-shaped and blot retinal haemorrhages throughout all four quadrants ;
- Markedly engorged, tortuous, dilated retinal veins;
Widespread cotton wool spots (microinfarcts of the nerve fibre layer) and optic disc oedema.
Late Complication: Ischaemic CRVO releases vascular endothelial growth factor (VEGF), stimulating abnormal neovascularization of the iris ( rubeosis iridis ) and filtration angle, precipitating intractable, painful neovascular glaucoma , classically occurring around 90 to 100 days post-occlusion ( "100-day glaucoma" ).
Management: Intravitreal anti-VEGF agents (aflibercept, ranibizumab) or intravitreal dexamethasone implants for macular oedema; panretinal photocoagulation (PRP) laser for anterior segment neovascularization.
Anterior Ischaemic Optic Neuropathy (AION)
Presentation: Sudden, painless monocular visual loss with a characteristic altitudinal visual field defect (sharp loss of either the superior or inferior hemifield respecting the horizontal meridian).
Arteritic AION (A-AION): Secondary to Giant Cell Arteritis (GCA / Temporal Arteritis) in patients > 50 years. Occlusion of the posterior ciliary arteries causes transmural necrotizing vasculitis. Accompanied by temporal headache, scalp tenderness, jaw claudication, and constitutional symptoms. Fundoscopy demonstrates a chalky-white, pale swollen optic disc . ESR (> 50–100 mm/h) and CRP are markedly elevated. Management: Immediate IV methylprednisolone (500 mg – 1 g daily for 3 days) followed by high-dose oral prednisolone (60 mg daily) to prevent irreversible contralateral visual loss (which occurs in up to 50% within days). Never delay corticosteroids for temporal artery biopsy!
Non-Arteritic AION (NA-AION): Nocturnal hypotension and microvascular hypoperfusion in patients with small, crowded optic discs ("disc at risk", absent physiological cup). Normal ESR/CRP.
Retinal Detachment
Pathophysiology: Separation of the neurosensory retina from the underlying retinal pigment epithelium (RPE), most commonly rhegmatogenous (vitreous traction creates a full-thickness retinal tear in myopic eyes or after cataract surgery).
Classic Symptom Cascade:
- Photopsia: Flashes of light in the peripheral visual field (mechanical vitreoretinal traction);
- Floaters: Sudden burst of black specks or spiderwebs (vitreous hemorrhage or pigment release);
- Progressive Field Defect: A dense, dark "curtain" or "shadow" descending or ascending across the visual field;
Central Vision Loss: Sudden catastrophic loss of visual acuity occurs when the detachment involves the macula ("macula off").
Fundoscopy: Elevated, folded, mobile, grey-white opalescent retina with loss of choroidal vascular details.